Insulin lispro (Humalog)
Insulin lispro (Humalog) is a pharmaceutical drug with 6 clinical trials. Historical success rate of 83.3%.
Success Metrics
Based on 5 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
83.3%
5 of 6 finished
16.7%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of a New LY900014 Formulation in Healthy Participants
A Study of Various Formulations of LY900014 in Healthy Participants
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
Clinical Trials (6)
A Study of a New LY900014 Formulation in Healthy Participants
A Study of Various Formulations of LY900014 in Healthy Participants
A Study of LY900014 Administered in Participants With Type 1 Diabetes Using an Insulin Pump
A Trial to Investigate Post Prandial Blood Glucose Control With Fast-acting Human Insulin HinsBet® Compared to Insulin Lispro (Humalog®) and Regular Human Insulin (Huminsulin® Normal) After Ingestion of a Standardized Meal in Subjects With T1DM
A Clinical Trial Comparing Efficacy and Safety of Exubera® and Humalog®
Feasibility Study of the Effect of Intra-Dermal Insulin Injection on Blood Glucose Levels After Eating
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6